https://www.selleckchem.com/pr....oducts/ipilimumab.ht
non-HGSC], body mass index, smoking status, menopausal status, and aspirin use. Women with the highest versus lowest quartile (Q) levels of CXCL13 had a 72% increased ovarian cancer risk (OR = 1.72; 95% CI = 1.04-2.83; = 0.007). The positive association with CXCL13 was stronger in magnitude for non-HGSC, overweight or obese women, and postmenopausal women, although only menopausal status demonstrated statistically significant heterogeneity ( = 0.04). The remaining biomarkers were not associated with risk. This first evidence that pre
Like
Comment
Share
